Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,210 | Dovepress* | 4,535+ | 997 | 5,532 | |
| PubMed Central* | 675 | 230 | 905 | ||
| Totals | 5,210 | 1,227 | 6,437 | ||
| *Since 8 April 2019 | |||||
View citations on PubMed Central and Google Scholar